Closed-loop insulin delivery – what lies between where we are and where we are going?
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Closed-loop insulin delivery in individuals with diabetes can potentially lead to near-normal glucose profiles. To this end, existing subcutaneous glucose sensors and external insulin pumps can be linked with an insulin delivery algorithm to create a completely automated closed-loop system. This paper reviews current research into the development of such a system, with particular emphasis on creating a system emulating the physiological properties of the beta-cell. Issues related to using subcutaneous interstitial fluid for glucose sensing and insulin delivery are reviewed. Criteria for optimising the system are discussed using historical data. Existing strategies for open-loop pump therapy are presented with the objective of defining a path to advance from the existing physician/patient determined insulin therapy to a completely automated system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 1×
“Briefly, the main arguments are that the β-cell adjusts the ratio of first-to-second-phase insulin release to compensate for the delay in insulin action [41], and that it adapts the magnitude of its response to keep the product of insulin sensitivity (SI) and the AUC of the first-phase insulin response constant: the c…”
BackgroundIntensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa022314 · Cited by 815 · cited 1×
“Benefits of intensive insulin therapy were clearly established in the Diabetes Control and Complications Trial (DCCT) [8] and continue to be observed [9,10].”
BackgroundDoyle (Boland), E. A., Weinzimer, S. A., Steffen, A. T., Ahern, J. A. H., Vincent, M., & Tamborlane, W. V. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1554 · Cited by 373 · cited 1×
“At present, multiple daily insulin injection therapy remains common, continuous subcutaneous insulin infusion shows benefit in reducing haemoglobin A1c in some [12,13], but not all, [14] studies, and continuous glucose monitoring data are only available retrospectively [15].”
BackgroundOral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity
Breda, E., Cavaghan, M. K., Toffolo, G., Polonsky, K. S., & Cobelli, C. (2001) · Diabetes · doi:10.2337/diabetes.50.1.150 · Cited by 320
Mudaliar, S. R., Lindberg, F. A., Joyce, M., Beerdsen, P., Strange, P., Lin, A., & Henry, R. R. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1501 · Cited by 276
Dalla Man, C., Caumo, A., Basu, R., Rizza, R., Toffolo, G., & Cobelli, C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00319.2003 · Cited by 198 · cited 1×
“Glucose tracer methods are emerging for estimating the rate [81,82] and this will likely aid in further developments.”
BackgroundModels of subcutaneous insulin kinetics. A critical review
Nucci, G., & Cobelli, C. (2000) · Computer Methods and Programs in Biomedicine · doi:10.1016/s0169-2607(00)00071-7 · Cited by 189
Modeling Phasic Insulin Release
Nesher, R., & Cerasi, E. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s53 · Cited by 179
Cited by
Hovorka, R., Allen, J. M., Elleri, D., Chassin, L. J., Harris, J., Xing, D., Kollman, C., Hovorka, T., Larsen, A. M. F., Nodale, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61998-x · Cited by 450
Closed-loop insulin delivery from bench to clinical practice
Hovorka, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.32 · Cited by 342
Hovorka, R., Kumareswaran, K., Harris, J., Allen, J. M., Elleri, D., Xing, D., Kollman, C., Nodale, M., Murphy, H. R., Dunger, D. B., et al. (2011) · BMJ · doi:10.1136/bmj.d1855 · Cited by 244
“Recent technological advances provide an opportunity to combine three technologies—continuous glucose monitors, insulin pumps, and a computerised control algorithm. This forms the basis of a closed loop system, sometimes termed an artificial pancreas, and characterised by algorithm driven insulin delivery according to…”
BackgroundA comparison among three maximal mathematical models of the glucose-insulin system
Pompa, M., Panunzi, S., Borri, A., & De Gaetano, A. (2021) · PLOS ONE · doi:10.1371/journal.pone.0257789 · Cited by 24
Panunzi, S., Pompa, M., Borri, A., Piemonte, V., & De Gaetano, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237215 · Cited by 21
Metadata
- Authors
- Steil, G. M., & Rebrin, K.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2005-03
- Volume
- 2
- Issue
- 2
- Pages
- 353-362
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W1972160978
- Cited by
- 39
- References
- 9
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Closed-loop insulin delivery – what lies between where we are and where we are going? https://app.cochat.ai/papers/10.1517/17425247.2.2.353
- The paper
- Steil, G. M., & Rebrin, K. (2005). Closed-loop insulin delivery – what lies between where we are and where we are going? Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2.2.353
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.